Ivacaftor treatment in children 12 to <24 months old with cystic fibrosis and a CFTR gating mutation: results from the phase 3 ARRIVAL study

Rosenfeld Margaret, Wainwright Claire, Higgins Mark, Wang Linda, Charlotte McKee, Daniel Campbell, Simon Tian, Jennifer Schneider, Steven Cunningham, Jane Davies

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalThe Lancet Respiratory Medicine
Publication statusPublished - 7 Jun 2018

Cite this